Teva Pharmaceutical Industries (TEVA) Scheduled to Post Quarterly Earnings on Wednesday

Teva Pharmaceutical Industries (NYSE:TEVA) will be announcing its earnings results before the market opens on Wednesday, November 6th. Analysts expect the company to announce earnings of $0.62 per share for the quarter. Investors interested in participating in the company’s conference call can do so using this link.

Teva Pharmaceutical Industries Stock Up 0.1 %

TEVA stock opened at $18.45 on Monday. Teva Pharmaceutical Industries has a 1-year low of $8.55 and a 1-year high of $19.08. The business has a fifty day moving average price of $18.02 and a 200-day moving average price of $16.98. The company has a debt-to-equity ratio of 2.52, a current ratio of 0.89 and a quick ratio of 0.59. The stock has a market capitalization of $20.90 billion, a P/E ratio of -47.31, a P/E/G ratio of 1.33 and a beta of 0.87.

Analysts Set New Price Targets

Several analysts recently commented on TEVA shares. JPMorgan Chase & Co. lifted their price objective on Teva Pharmaceutical Industries from $16.00 to $18.00 and gave the stock a “neutral” rating in a report on Monday, October 21st. Argus raised Teva Pharmaceutical Industries from a “hold” rating to a “buy” rating and set a $20.00 price objective for the company in a report on Wednesday, July 10th. UBS Group lifted their price objective on Teva Pharmaceutical Industries from $24.00 to $26.00 and gave the stock a “buy” rating in a report on Tuesday, September 3rd. StockNews.com raised Teva Pharmaceutical Industries from a “buy” rating to a “strong-buy” rating in a report on Thursday, October 17th. Finally, Barclays boosted their price target on Teva Pharmaceutical Industries from $22.00 to $25.00 and gave the company an “overweight” rating in a report on Wednesday, October 23rd. Two research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Teva Pharmaceutical Industries has an average rating of “Moderate Buy” and an average price target of $19.67.

About Teva Pharmaceutical Industries

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products.